The Centers for Disease Control and Prevention abruptly ordered its staff to cease all collaboration with the World Health ...

Moderna and Pfizer are in talks with the federal government over a potential avian flu vaccine program, the head of the U.S. government’s pandemic response administration said late Wednesday.

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

At the healthcare conference, Moderna lowered expected 2025 revenue to the range of $1.5 billion to $2.5 billion -- down from ...

Biopharma executives were busy Monday, striking high-value deals and providing updates on cancer, obesity and vaccine ...

Every time a shuttle docks with the International Space Station (ISS), a delicate dance unfolds between the shuttle's docking ...

Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...

Leerink Partners analyst Mani Foroohar has maintained their bearish stance on MRNA stock, giving a Sell rating yesterday.Invest with ...

BioNTech and Pfizer have since countersued, seeking to dismiss Moderna’s suit and further claiming that its patents are invalid and not infringed, and make claims that “far exceed its contribu ...

Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...

According to Jefferies analyst Michael Yee, COVID vaccinations involving Moderna, Pfizer and Novavax products dropped by 8% at the end of 2024 versus the year prior. And RSV, which was targeted by ...

Moderna lowered its 2025 sales guidance by roughly $1 billion ... FTC sues drug middlemen for allegedly inflating insulin prices Pfizer says drug for deadly cancer condition that causes weight loss ...